UnitedHealth is reeling from a nearly 20% stock rout after warning investors about its first revenue decline in decades

UnitedHealth shares plunged about 20% after the company warned 2026 revenue will be “greater than” $439 billion — roughly a 2% decline versus last year and well below analyst estimates — marking the first annual revenue contraction since the late 1980s. Fourth-quarter revenue was roughly $113.2 billion (up ~12% YoY) while full‑year 2025 revenue was about $447.6 billion (up 12%), but net income collapsed to ~$10 million (1¢ per share) after ~$1.6 billion in after‑tax restructuring and related charges and adjusted EPS fell to $2.11 from $6.81 a year earlier; management still guided at least $17.75 in adjusted EPS for 2026. Management cites regulatory pressure (including effects from the OBBBA and a new coding model), divestitures, higher medical trends, membership losses (1.3–1.4M Medicare Advantage members plus up to 2.8M projected exits) and a Change Healthcare cyber incident as drivers of the reset — a development that materially reprices UnitedHealth and pressures peers in the Medicare Advantage market.

Analysis

Market structure: The immediate winners are non‑MA healthcare providers (hospitals, urgent care), PBMs and diversified payers that rely less on Medicare Advantage; losers are MA‑centric insurers (UNH, HUM) and businesses tied to Change Healthcare. Competitive dynamics will favor regional/low‑cost plans as 1.3–1.4M reported UHC MA churn (up to 2.8M industry‑wide risk) forces price competition and weakens pricing power; expect slower premium growth and higher medical trend pass‑throughs for 6–18 months. Cross‑asset: expect IG corporate spread widening of 15–40bps for large insurers, elevated equity IV (+30–60% short term), and heavier bid for protection (CDS); commodities and FX impacts should be muted beyond a modest USD safe‑haven bid during volatility spikes.

Risk assessment: Tail risks include a CMS 2027 payment cut >3% (material revenue hit), protracted Change Healthcare operational outages or regulatory fines >$1B, and political/legal actions that further shrink Medicaid/ACA pools. Time horizons: days–weeks = equity/IV shock and credit spread moves; months = enrollment/claims normalization through next AEP and CMS rule finalization; years = structural MA market contraction if OBBBA effects persist. Hidden dependencies: Optum’s margin contribution and any asset divestitures are critical — failure to execute could force deeper write‑downs. Key catalysts: CMS final 2027 rates, next quarter MA membership print, and major regulatory pronouncements in 30–90 days.

Trade implications: Direct plays — establish a 1.5–2% portfolio short on UNH via stock or buy a 3‑month 1×1 put spread (~290/240 if UNH ~282) sized to 2% NAV; alternatively buy 6‑month 270 puts if skew favors. Pair trade — long 2% CI (Cigna) or HCA (HCA) vs 2% short UNH for 3–6 months to capture relative resilience of diversified payers/hospitals. Options — buy 3–6 month UNH puts rather than selling premium given IV; consider selling short‑dated calls on oversold HUM only if IV contracts >25% in 2–4 weeks. Sector rotation — reduce Managed Care exposure by 40–60% and redeploy into hospitals (HCA) and diversified payers (CI) over next 2–8 weeks; exit/trim shorts if UNH >$340 or CMS cuts <2%.

Contrarian angles: The market may be overpricing a permanent revenue collapse; Optum services and post‑restructuring cost cuts imply UNH can re‑accelerate earnings within 12–18 months once member mix stabilizes, so consider long recovery exposure. Historical analog: large insurer selloffs tied to enrollment or rate shocks often reverse 6–12 months after regulatory clarity and membership stabilizes. Unintended consequences include oversold bond markets — buy IG paper on spread dislocations if UNH 5‑year CDS widens >50bps. Tactical contrarian: if UNH falls >35% (<~$185), scale into 12–18 month OTM calls (e.g., strikes 40–60% OTM) sized 0.5–1% as asymmetric recovery lottery.

Key Decisions for Investors

• Establish a 1.5–2% portfolio short on UNH over the next 2–4 weeks via stock or a 3‑month put spread (approx. 290/240 if UNH ~282); target exit or re‑rate if UNH >$340 or CMS final 2027 cuts come in <2%.
• Initiate a 2% pair trade: long 1% CI (Cigna) or HCA (HCA) and short 1% UNH for 3–6 months to capture relative resilience of diversified payers/hospitals versus MA exposure.
• Buy 3–6 month UNH puts (or put spreads) sized to 1–1.5% NAV instead of selling premium; add if UNH breaks below $220, increase put sizing to 2–3%.
• Reduce Managed‑Care sector exposure by 40–60% (cut positions in UNH/HUM/managed‑care ETFs) and redeploy funds into hospitals (HCA, target 1–2% position) and diversified payers (CI, target 1–2%) within 2–8 weeks.
• Prepare a contrarian recovery sleeve: if UNH declines >35% (below ~$185), purchase 12–18 month OTM calls (40–60% OTM) sized 0.5–1% as asymmetric upside; concurrently buy IG UNH bonds or CDS protection if 5‑yr CDS widens >50bps.